Home » Global Angioedema Treatment market from 2016 to 2023 scrutinized in new research

Global Angioedema Treatment market from 2016 to 2023 scrutinized in new research

According to the latest report published by Credence Research, Inc. “Angioedema Treatment Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the  angioedema market was valued at USD 895.4 Mn in 2015, and is expected to reach USD 1,658.0  Mn by 2022, expanding at a CAGR of 9.2% from 2016 to 2022.

Market Insights

Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. North America is the largest regional market at a market share of over 41% in 2015, and the dominance of this region is anticipated to continue through 2022.

Browse the full report Angioedema Treatment Market @ http://www.credenceresearch.com/report/angioedema-treatment-market

Rising incidence of angioedema and high awareness about treatment and the management of angioedema together drive the North America angioedema market. Asia Pacific is expected to be the fastest growing market in the global angioedema market due to rising prevalence rate in the countries like Japan, China and others. Moreover, the growing research and development in the drug discovery of angioedema would further drive the market during the forecast period.

The treatment types include Antihistamines, Corticosteroids, Autoimmune drugs, antifibrinolytic agents and blood protein controllers. Antihistamines and Corticosteroids accounted for approximately 45% – 50% of the total market share because these are the first line therapies preferred by the medical practitioners and majorly used as supportive therapies and most accessible source of treatment across the globe.

Request For Customization: http://www.credenceresearch.com/request-for-customization/58017

Despite the high cost of new treatment options in comparison to older therapies such as attenuated androgens and antifibrinolytic agents, they are popular with physicians due to the superior control offered over symptoms such as subcutaneous and abdominal swelling. These highly priced drugs have therefore managed to capture a high prescription share. Hence, introduction of new drugs with further improved effectiveness and safety will drive the global angioedema market during the forecast period.


About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith (Global Sales Manager)

Address: 105 N 1st ST #429, SAN JOSE, CA 95103 US

E-mail: sales@credenceresearch.com 

Ph: 1-800-361-8290

Web: http://www.credenceresearch.com

Name of author

Name: satyamspot

Leave a Reply

Your email address will not be published. Required fields are marked *